304 filings
Page 8 of 16
6-K
1hsi 3vc4
14 Mar 17
GW Pharmaceuticals Announces Results of Annual General Meeting
12:00am
6-K
uqdqz58 jj41gxrh9u
7 Mar 17
GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director - UK
12:00am
SC 13G/A
yn10qg0skot12c6kdga
14 Feb 17
GW Pharmaceuticals PLC
12:00am
SC 13G/A
sj33m20wfvtj
14 Feb 17
Beneficial ownership report (amended)
12:00am
SC 13G/A
pxixp b7r0c9sb7
14 Feb 17
GW Pharmaceuticals PLC
12:00am
SC 13G
f5kl0yfh fmtp
14 Feb 17
GW Pharmaceuticals PLC
12:00am
SC 13G/A
y80uskrxfladyzo9xwi
13 Feb 17
GW Pharmaceuticals PLC
12:00am
6-K
d2lrg f200n
13 Feb 17
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt
12:00am
6-K
3kva60p9jfvt zsjzu
7 Feb 17
GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational
12:00am
6-K
gocbitg60nqn2oj
9 Jan 17
Current report (foreign)
12:00am
CT ORDER
xzppqr
22 Dec 16
Confidential treatment order
12:00am
6-K
555teeq 9su4n8d27
20 Dec 16
Current report (foreign)
12:00am
6-K
oj6kztpvept0pzdui2
5 Dec 16
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress
12:00am
6-K
d4hufg h9wo4w
3 Nov 16
Current report (foreign)
12:00am
6-K
mx8s8l7
26 Oct 16
Current report (foreign)
12:00am
6-K
qhh15dcel
19 Oct 16
GW Pharmaceuticals plc Announces Intention to Continue Trading Exclusively on NASDAQ and Planned Cancellation of Trading of Ordinary Shares on AIM
12:00am
6-K
ajwtksfxq93ac5rrqhg
7 Oct 16
Current report (foreign)
12:00am
6-K
xyhe9i8bujvrbt0b
26 Sep 16
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
12:00am
6-K
o9th9izz06zo t8drl6a
14 Sep 16
Current report (foreign)
12:00am